Your browser doesn't support javascript.
loading
Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible.
Jensen, Taylor J; Goodman, Aaron M; Ellison, Christopher K; Holden, Kimberly A; Kato, Shumei; Kim, Lisa; Daniels, Gregory A; Fitzgerald, Kerry; McCarthy, Erin; Nakashe, Prachi; Mazloom, Amin R; Almasri, Eyad; McLennan, Graham; Grosu, Daniel S; Eisenberg, Marcia; Kurzrock, Razelle.
Afiliación
  • Jensen TJ; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California. jenset2@labcorp.com.
  • Goodman AM; Laboratory Corporation of America, Durham, North Carolina.
  • Ellison CK; Department of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, Moores Cancer Center, University of California, San Diego.
  • Holden KA; Department of Medicine, Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California, San Diego.
  • Kato S; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
  • Kim L; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
  • Daniels GA; Department of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, Moores Cancer Center, University of California, San Diego.
  • Fitzgerald K; Department of Medicine, Division of Precision Medicine, Moores Cancer Center, University of California, San Diego.
  • McCarthy E; Department of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, Moores Cancer Center, University of California, San Diego.
  • Nakashe P; Department of Medicine, Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, Moores Cancer Center, University of California, San Diego.
  • Mazloom AR; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
  • Almasri E; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
  • McLennan G; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
  • Grosu DS; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
  • Eisenberg M; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
  • Kurzrock R; Sequenom, Inc, a wholly owned subsidiary of Laboratory Corporation of America Holdings, San Diego, California.
Mol Cancer Ther ; 20(11): 2274-2279, 2021 11.
Article en En | MEDLINE | ID: mdl-34465593
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Variaciones en el Número de Copia de ADN / Ácidos Nucleicos Libres de Células / Secuenciación Completa del Genoma / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Variaciones en el Número de Copia de ADN / Ácidos Nucleicos Libres de Células / Secuenciación Completa del Genoma / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article